{"hands_on_practices": [{"introduction": "The efficacy of an RNA therapeutic is fundamentally dependent on the chemical integrity of the RNA molecule itself, both during storage and after administration. This practice explores how to quantify the stability of an mRNA formulation using the principles of chemical kinetics. By applying a first-order degradation model, we can predict the shelf-life of these advanced medicines, a critical aspect of their development and distribution [@problem_id:4988731].", "problem": "Messenger ribonucleic acid (mRNA) therapeutics rely on the chemical integrity of the mRNA molecule during storage to permit translation after administration. Suppose an mRNA formulation stored at $4\\,^{\\circ}\\mathrm{C}$ exhibits first-order degradation of intact strands under these conditions. Let $C(t)$ denote the amount of intact mRNA at time $t$ and $C_0$ the initial amount at $t=0$. The experimentally measured first-order degradation rate constant is $k = 0.002\\ \\text{day}^{-1}$. Using the fundamental definition of a first-order process that the rate of change in intact amount is proportional to the amount present, derive from first principles the expression for the fraction of intact mRNA remaining after $t=30$ days, and then compute its numerical value. Express your final answer as a unitless decimal and round to four significant figures.", "solution": "The problem requires the derivation of the fraction of intact messenger ribonucleic acid (mRNA) remaining after a specified time, based on the principle of first-order degradation kinetics.\n\nThe problem states that the process is first-order, which is defined by the rate of change in the amount of intact mRNA, $C(t)$, being directly proportional to the amount present at that time, $C(t)$. As this is a degradation process, the amount of intact mRNA decreases over time, so the rate of change is negative. This principle can be formalized as a differential equation:\n$$\n\\frac{dC(t)}{dt} = -k C(t)\n$$\nwhere $k$ is the first-order degradation rate constant. The givens are the rate constant $k = 0.002\\ \\text{day}^{-1}$ and the initial amount of intact mRNA at time $t=0$, which is denoted as $C_0$.\n\nTo find the expression for $C(t)$, we must solve this first-order linear ordinary differential equation. We can achieve this by the method of separation of variables. Rearranging the equation to group terms involving $C$ on one side and terms involving $t$ on the other side yields:\n$$\n\\frac{1}{C(t)} dC(t) = -k dt\n$$\nNext, we integrate both sides of the equation. We integrate the left side from the initial amount $C_0$ at time $t=0$ to the amount $C(t)$ at a general time $t$. The right side is integrated from time $0$ to $t$:\n$$\n\\int_{C_0}^{C(t)} \\frac{1}{C'} dC' = \\int_{0}^{t} -k dt'\n$$\nHere, $C'$ and $t'$ are used as dummy variables for integration.\n\nEvaluating the definite integrals gives:\n$$\n[\\ln|C'|]_{C_0}^{C(t)} = [-kt']_{0}^{t}\n$$\nSince the amount of a substance, $C(t)$, must be non-negative, the absolute value is redundant.\n$$\n\\ln(C(t)) - \\ln(C_0) = (-kt) - (-k \\cdot 0)\n$$\nUsing the property of logarithms, $\\ln(a) - \\ln(b) = \\ln(a/b)$, the left side simplifies to:\n$$\n\\ln\\left(\\frac{C(t)}{C_0}\\right) = -kt\n$$\nThe problem asks for the fraction of intact mRNA remaining, which is precisely the ratio $\\frac{C(t)}{C_0}$. To solve for this fraction, we exponentiate both sides of the equation:\n$$\n\\exp\\left(\\ln\\left(\\frac{C(t)}{C_0}\\right)\\right) = \\exp(-kt)\n$$\nThis simplifies to the general expression for the fraction of intact mRNA remaining at any time $t$:\n$$\n\\frac{C(t)}{C_0} = \\exp(-kt)\n$$\nThis completes the derivation from first principles.\n\nNow, we must compute the numerical value of this fraction at $t=30$ days. We are given the values:\n- Rate constant, $k = 0.002\\ \\text{day}^{-1}$\n- Time, $t = 30\\ \\text{days}$\n\nSubstituting these values into the derived expression:\n$$\n\\frac{C(30)}{C_0} = \\exp(-0.002 \\times 30)\n$$\nFirst, calculate the exponent:\n$$\n-0.002 \\times 30 = -0.06\n$$\nSo, the fraction remaining is:\n$$\n\\frac{C(30)}{C_0} = \\exp(-0.06)\n$$\nCalculating the numerical value:\n$$\n\\exp(-0.06) \\approx 0.9417645331...\n$$\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $9$, $4$, $1$, and $7$. The fifth significant figure is $6$, which is greater than or equal to $5$, so we round up the fourth significant figure.\n$$\n0.94176... \\approx 0.9418\n$$\nThus, the fraction of intact mRNA remaining after $30$ days is approximately $0.9418$.", "answer": "$$\\boxed{0.9418}$$", "id": "4988731"}, {"introduction": "Moving from drug stability to biological activity, we next examine how to model the primary pharmacodynamic effect of an RNA interference therapeutic. Small interfering RNAs (siRNAs) function by silencing the production of a target protein. This exercise guides you through deriving the time course of protein concentration following the administration of an siRNA, using a standard and widely applicable protein turnover model. Understanding these dynamics is essential for predicting the onset and duration of a drug's therapeutic effect [@problem_id:4988781].", "problem": "A pharmacology laboratory is evaluating a small interfering ribonucleic acid (siRNA) therapeutic that reduces translation of a target protein by decreasing the availability of its messenger ribonucleic acid (mRNA). Assume the following foundational bases grounded in the Central Dogma of molecular biology and standard turnover kinetics:\n- Translation produces the protein at a zero-order rate, denoted by $k_{in}(t)$, because under saturating ribosomal capacity within the tested range the production rate is effectively independent of the current protein concentration.\n- Protein loss occurs via first-order degradation with rate constant $k_{out}$, so that the degradation flux is $k_{out} P(t)$.\n\nBefore therapy ($t < 0$), the system is at steady state with a constant production rate $k_{in,0}$ and a constant degradation rate constant $k_{out}$. At time $t = 0$, an intravenous dose of the siRNA is administered, and within minutes it produces a step reduction in translation such that for $t \\geq 0$ the production rate becomes $k_{in,1} = (1 - f) k_{in,0}$, where $f$ is a constant fractional silencing level satisfying $0 < f < 1$. Assume $k_{out}$ is unchanged by the therapy and remains constant in time.\n\nStarting only from the above mechanistic bases (zero-order production and first-order loss), derive the turnover differential equation for the target protein concentration $P(t)$, and then solve for the full time course $P(t)$ for $t \\geq 0$ given the initial condition that the system is at its pre-therapy steady state at $t = 0$.\n\nExpress your final $P(t)$ as a single closed-form analytic expression in terms of $k_{in,0}$, $k_{out}$, $f$, and $t$. No numerical evaluation is required, and no units should be included in the final expression.", "solution": "The Central Dogma of molecular biology states that genetic information flows from deoxyribonucleic acid (DNA) to ribonucleic acid (RNA) to protein. In the pharmacology context, small interfering ribonucleic acid (siRNA) reduces the abundance of messenger ribonucleic acid (mRNA), thereby decreasing the translation rate of the target protein. A standard and widely used mechanistic description of protein turnover assumes zero-order production and first-order degradation within the operating regime of interest.\n\nLet $P(t)$ denote the concentration of the target protein as a function of time. By mass balance, the rate of change of $P(t)$ equals the difference between production and loss:\n$$\n\\frac{dP(t)}{dt} = k_{in}(t) - k_{out} P(t),\n$$\nwhere $k_{in}(t)$ is the time-dependent zero-order production rate and $k_{out}$ is the constant first-order degradation rate constant.\n\nBefore therapy, for $t < 0$, the system is at steady state with $k_{in}(t) = k_{in,0}$ and $\\frac{dP}{dt} = 0$, so the steady-state concentration $P_{ss,0}$ satisfies\n$$\n0 = k_{in,0} - k_{out} P_{ss,0} \\quad \\Rightarrow \\quad P_{ss,0} = \\frac{k_{in,0}}{k_{out}}.\n$$\nBecause the system is at steady state at $t = 0$, the initial condition is\n$$\nP(0) = \\frac{k_{in,0}}{k_{out}}.\n$$\n\nAfter therapy is administered at $t = 0$, the production rate undergoes a step reduction due to mRNA silencing such that for $t \\geq 0$,\n$$\nk_{in}(t) = k_{in,1} = (1 - f) k_{in,0},\n$$\nwith $0 < f < 1$. The degradation rate constant $k_{out}$ remains unchanged. Therefore, for $t \\geq 0$, the differential equation becomes a linear, constant-coefficient ordinary differential equation (ODE):\n$$\n\\frac{dP(t)}{dt} + k_{out} P(t) = k_{in,1}.\n$$\n\nTo solve this ODE, we use the integrating factor method. The integrating factor is\n$$\n\\mu(t) = \\exp\\!\\left( \\int k_{out} \\, dt \\right) = \\exp(k_{out} t).\n$$\nMultiplying both sides of the ODE by $\\exp(k_{out} t)$ gives\n$$\n\\exp(k_{out} t) \\frac{dP(t)}{dt} + k_{out} \\exp(k_{out} t) P(t) = k_{in,1} \\exp(k_{out} t).\n$$\nThe left-hand side is the derivative of $\\exp(k_{out} t) P(t)$:\n$$\n\\frac{d}{dt} \\left[ \\exp(k_{out} t) P(t) \\right] = k_{in,1} \\exp(k_{out} t).\n$$\nIntegrating both sides from $0$ to $t$,\n$$\n\\exp(k_{out} t) P(t) - \\exp(k_{out} \\cdot 0) P(0) = \\int_{0}^{t} k_{in,1} \\exp(k_{out} s) \\, ds.\n$$\nCompute the integral on the right-hand side:\n$$\n\\int_{0}^{t} k_{in,1} \\exp(k_{out} s) \\, ds = \\frac{k_{in,1}}{k_{out}} \\left[ \\exp(k_{out} s) \\right]_{0}^{t} = \\frac{k_{in,1}}{k_{out}} \\left( \\exp(k_{out} t) - 1 \\right).\n$$\nSubstituting back and solving for $P(t)$,\n$$\n\\exp(k_{out} t) P(t) - P(0) = \\frac{k_{in,1}}{k_{out}} \\left( \\exp(k_{out} t) - 1 \\right),\n$$\n$$\nP(t) = \\frac{k_{in,1}}{k_{out}} + \\left[ P(0) - \\frac{k_{in,1}}{k_{out}} \\right] \\exp(-k_{out} t).\n$$\n\nWe now substitute the initial condition $P(0) = \\frac{k_{in,0}}{k_{out}}$ and $k_{in,1} = (1 - f) k_{in,0}$:\n$$\nP(t) = \\frac{(1 - f) k_{in,0}}{k_{out}} + \\left[ \\frac{k_{in,0}}{k_{out}} - \\frac{(1 - f) k_{in,0}}{k_{out}} \\right] \\exp(-k_{out} t).\n$$\nThe bracket simplifies to $\\frac{f k_{in,0}}{k_{out}}$, yielding\n$$\nP(t) = \\frac{(1 - f) k_{in,0}}{k_{out}} + \\frac{f k_{in,0}}{k_{out}} \\exp(-k_{out} t).\n$$\n\nThis expression is the closed-form time course of the protein concentration after a step reduction in production rate due to mRNA silencing, derived from zero-order production and first-order degradation principles.", "answer": "$$\\boxed{\\frac{(1 - f) k_{in,0}}{k_{out}} + \\frac{f k_{in,0}}{k_{out}} \\exp(-k_{out} t)}$$", "id": "4988781"}, {"introduction": "A key challenge and opportunity in genetic medicine is designing drugs with exquisite specificity. This final practice delves into the biophysical principles that enable antisense oligonucleotides (ASOs) to distinguish between RNA targets that may differ by only a single nucleotide, a property known as allele specificity. By modeling how a mismatch's position within the drug-target complex affects RNase H cleavage, you will uncover the basis for rationally designing highly selective ASO therapies for genetic diseases [@problem_id:4988756].", "problem": "A DNA-Locked Nucleic Acid (LNA) gapmer antisense oligonucleotide (ASO) recruits Ribonuclease H (RNase H) to cleave a target ribonucleic acid (RNA) when a DNA gap region forms a productive DNA:RNA heteroduplex. Consider single-turnover, enzyme-saturating conditions in which the observed cleavage efficiency is limited by the formation of a productive RNase H–competent complex on the ASO:RNA duplex. Use the following well-tested physical chemistry bases: (i) under a two-state equilibrium between bound and unbound complex, the association constant satisfies $K_{a} \\propto \\exp\\!\\left(-\\Delta G_{\\text{bind}}/(R T)\\right)$, where $\\Delta G_{\\text{bind}}$ is the standard Gibbs free energy of binding, $R$ is the gas constant, and $T$ is the absolute temperature; (ii) for a single nucleotide mismatch, the duplex free energy penalty relative to a perfect match is $\\Delta\\Delta G>0$; (iii) RNase H recognition is localized to a footprint centered in the DNA gap, so that the effective free energy penalty contributed by a mismatch at integer position $x$ (in nucleotides, with $x=0$ at the footprint center) is attenuated by a positional weight $w(x)$ reflecting how strongly position $x$ contributes to productive binding.\n\nAssume a Gaussian positional weight for the RNase H footprint, $w(x)=\\exp\\!\\left(-\\frac{x^{2}}{2\\sigma^{2}}\\right)$, and that a central mismatch has a penalty $\\Delta\\Delta G_{0}$ so the effective penalty at position $x$ is $\\Delta\\Delta G_{\\text{eff}}(x)=\\Delta\\Delta G_{0}\\,w(x)$. Let $E_{0}$ denote the cleavage efficiency for a perfectly matched allele and $E(x)$ the efficiency when the allele presents a single mismatch at position $x$. Derive, from the stated bases, the analytical expression for the relative cleavage efficiency $r(x)=\\frac{E(x)}{E_{0}}$ as a function of $\\Delta\\Delta G_{0}$, $R$, $T$, and $w(x)$.\n\nThen, using $\\Delta\\Delta G_{0}=3.0~\\text{kcal}\\,\\text{mol}^{-1}$, $\\sigma=1.5~\\text{nt}$, $T=310~\\text{K}$, and $R=1.987~\\text{cal}\\,\\text{mol}^{-1}\\,\\text{K}^{-1}$, compute the maximum theoretical allele selectivity $S_{\\max}=\\frac{E_{0}}{E(x)}$ achievable by optimally placing the mismatch within the RNase H footprint. Round your final answer to three significant figures and express it as a decimal fraction (no percent sign).", "solution": "The first task is to derive an analytical expression for the relative cleavage efficiency $r(x) = \\frac{E(x)}{E_{0}}$. The problem states that under single-turnover, enzyme-saturating conditions, the observed cleavage efficiency is limited by the formation of a productive RNase H–competent complex. This implies a direct proportionality between the cleavage efficiency, $E$, and the equilibrium association constant, $K_a$, for the formation of this productive complex. We can write this relationship as $E \\propto K_{a}$.\n\nThe association constant is given by the thermodynamic relation $K_{a} \\propto \\exp(-\\Delta G_{\\text{bind}}/(RT))$, where $\\Delta G_{\\text{bind}}$ is the standard Gibbs free energy of binding for the productive complex, $R$ is the gas constant, and $T$ is the absolute temperature.\n\nFor the perfectly matched allele, the cleavage efficiency is $E_0$, and the binding free energy is $\\Delta G_{0, \\text{bind}}$. The corresponding association constant is:\n$$K_{a,0} \\propto \\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}}}{RT}\\right)$$\nTherefore, the efficiency is $E_0 = C \\cdot K_{a,0}$, where $C$ is a constant of proportionality.\n\nFor an allele with a single nucleotide mismatch at position $x$, the cleavage efficiency is $E(x)$. The problem states that a mismatch introduces a duplex free energy penalty $\\Delta\\Delta G > 0$. The effective penalty at position $x$, $\\Delta\\Delta G_{\\text{eff}}(x)$, adds to the binding free energy of the perfect match. Thus, the binding free energy for the mismatched case is:\n$$\\Delta G_{\\text{bind}}(x) = \\Delta G_{0, \\text{bind}} + \\Delta\\Delta G_{\\text{eff}}(x)$$\nThe corresponding association constant is:\n$$K_a(x) \\propto \\exp\\left(-\\frac{\\Delta G_{\\text{bind}}(x)}{RT}\\right) = \\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}} + \\Delta\\Delta G_{\\text{eff}}(x)}{RT}\\right)$$\nThe efficiency for the mismatched case is $E(x) = C \\cdot K_a(x)$.\n\nThe relative cleavage efficiency, $r(x)$, is the ratio $\\frac{E(x)}{E_{0}}$:\n$$r(x) = \\frac{C \\cdot K_a(x)}{C \\cdot K_{a,0}} = \\frac{K_a(x)}{K_{a,0}}$$\nSubstituting the expressions for the association constants:\n$$r(x) = \\frac{\\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}} + \\Delta\\Delta G_{\\text{eff}}(x)}{RT}\\right)}{\\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}}}{RT}\\right)}$$\nUsing the property of exponents $\\exp(a+b) = \\exp(a)\\exp(b)$, we can rewrite the numerator:\n$$r(x) = \\frac{\\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}}}{RT}\\right) \\exp\\left(-\\frac{\\Delta\\Delta G_{\\text{eff}}(x)}{RT}\\right)}{\\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}}}{RT}\\right)}$$\nThe term $\\exp\\left(-\\frac{\\Delta G_{0, \\text{bind}}}{RT}\\right)$ cancels, leaving:\n$$r(x) = \\exp\\left(-\\frac{\\Delta\\Delta G_{\\text{eff}}(x)}{RT}\\right)$$\nThe problem provides the expression for the effective penalty: $\\Delta\\Delta G_{\\text{eff}}(x) = \\Delta\\Delta G_{0}\\,w(x)$. Substituting this into the expression for $r(x)$ gives the final derived form:\n$$r(x) = \\exp\\left(-\\frac{\\Delta\\Delta G_{0}\\,w(x)}{RT}\\right)$$\nThis expression for $r(x)$ is a function of $\\Delta\\Delta G_{0}$, $R$, $T$, and $w(x)$, as required.\n\nThe second task is to compute the maximum theoretical allele selectivity, $S_{\\text{max}}$. The selectivity is defined as $S(x) = \\frac{E_{0}}{E(x)}$, which is the reciprocal of the relative efficiency $r(x)$.\n$$S(x) = \\frac{1}{r(x)} = \\frac{1}{\\exp\\left(-\\frac{\\Delta\\Delta G_{0}\\,w(x)}{RT}\\right)} = \\exp\\left(\\frac{\\Delta\\Delta G_{0}\\,w(x)}{RT}\\right)$$\nTo find the maximum selectivity, $S_{\\text{max}}$, we must maximize the function $S(x)$. Since $\\Delta\\Delta G_{0}$, $R$, and $T$ are all positive constants, maximizing $S(x)$ is equivalent to maximizing the positional weight function $w(x)$.\nThe positional weight is given by the Gaussian function $w(x)=\\exp\\left(-\\frac{x^{2}}{2\\sigma^{2}}\\right)$. The maximum value of this function occurs at its center, $x=0$. At this position, the argument of the exponent is $0$, and thus the maximum value of the weight is $w(0) = \\exp(0) = 1$.\nThe mismatch is optimally placed at the center of the RNase H footprint ($x=0$) to achieve maximum selectivity.\n\nThe maximum selectivity is therefore:\n$$S_{\\text{max}} = S(0) = \\exp\\left(\\frac{\\Delta\\Delta G_{0}\\,w(0)}{RT}\\right) = \\exp\\left(\\frac{\\Delta\\Delta G_{0}}{RT}\\right)$$\nWe are given the following values for the computation:\n$\\Delta\\Delta G_{0}=3.0~\\text{kcal}\\,\\text{mol}^{-1}$\n$R=1.987~\\text{cal}\\,\\text{mol}^{-1}\\,\\text{K}^{-1}$\n$T=310~\\text{K}$\n\nA unit conversion is necessary. We convert $\\Delta\\Delta G_{0}$ from $\\text{kcal}\\,\\text{mol}^{-1}$ to $\\text{cal}\\,\\text{mol}^{-1}$:\n$\\Delta\\Delta G_{0} = 3.0~\\text{kcal}\\,\\text{mol}^{-1} \\times \\frac{1000~\\text{cal}}{1~\\text{kcal}} = 3000~\\text{cal}\\,\\text{mol}^{-1}$.\n\nNow we can compute the value of the exponent:\n$$\\frac{\\Delta\\Delta G_{0}}{RT} = \\frac{3000~\\text{cal}\\,\\text{mol}^{-1}}{(1.987~\\text{cal}\\,\\text{mol}^{-1}\\,\\text{K}^{-1}) \\times (310~\\text{K})} = \\frac{3000}{615.97} \\approx 4.870361$$\nThe value of $S_{\\text{max}}$ is:\n$$S_{\\text{max}} = \\exp(4.870361) \\approx 130.3683$$\nThe problem requires rounding the final answer to three significant figures.\n$$S_{\\text{max}} \\approx 1.30 \\times 10^{2}$$", "answer": "$$\\boxed{1.30 \\times 10^2}$$", "id": "4988756"}]}